Dr. Goswami is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1631 N. Loop W.
Suite 250
Houston, TX 77008Phone+1 713-864-2710Fax+1 713-864-2708
Education & Training
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalFellowship, Cardiovascular Disease, 2002 - 2005
- Zucker School of Medicine at Hofstra/Northwell at Lenox Hill HospitalResidency, Internal Medicine, 1999 - 2002
- NYIT College Of Osteopathic MedicineClass of 1999
Certifications & Licensure
- LA State License 2024 - 2025
- TX State License 2009 - 2025
- WY State License 2019 - 2020
- NJ State License 2009 - 2011
- NY State License 2004 - 2009
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- 3 citationsLeft Ventricular Rupture After Impella® Placement During High-Risk Percutaneous Coronary InterventionIsmael A. Salas de Armas, Sachin Kumar, Ahmed Almustafa, Bindu Akkanti, M Hakan Akay
Cardiovascular Revascularization Medicine. 2020-11-01 - 3 citationsTranscatheter Treatment of Apicoaortic Conduit Dysfunction.Walid K. Abu Saleh, Rajiv Goswami, Odeaa Al Jabbari, Colin MacLeod Barker, Neal S. Kleiman
Journal of Cardiac Surgery. 2015-12-01 - 1 citationsBioprosthetic Mitral Transcatheter Transapical Valve-in-Valve Implantation for Mitral Stenosis in an End-Stage Renal Disease Patient.Kongkiat Chaikriangkrai, D O Rajiv Goswami, Stephen Little, Su Min Chang, Basal Ramlawi
Journal of Cardiac Surgery. 2015-09-01
Press Mentions
- Estimation of Drug-Likeness Properties of GC–MS Separated Bioactive Compounds in Rare Medicinal Pleione Maculata Using Molecular Docking Technique and SwissADME in Silico ToolsFebruary 24th, 2021
- Estimation of Drug-Likeness Properties of GC–MS Separated Bioactive Compounds in Rare Medicinal Pleione Maculata Using Molecular Docking Technique and SwissADME in Silico ToolsFebruary 24th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: